Is Wakix (pitolisant) affected by gastric pH?

Wakix (Pitolisant) and Gastric pH

Wakix absorption is not affected by gastric pH because it is acid-stable and does not require specific gastric conditions for absorption. 1

Pharmacokinetic Properties Independent of Gastric pH

Pitolisant is fundamentally different from proton pump inhibitors (PPIs) in its relationship to gastric acidity:

• Pitolisant is acid-stable, meaning it does not degrade in acidic environments and maintains its chemical structure regardless of gastric pH. 1

• Pitolisant is not a prodrug and does not require conversion to an active form through acid-dependent mechanisms, unlike PPIs which require acidic activation. 1

• Oral absorption of Wakix is approximately 90%, and this high bioavailability occurs independently of gastric conditions. 1

• Food has no clinically significant effect on pitolisant pharmacokinetics, further demonstrating that gastric contents and pH do not meaningfully alter absorption. 1

Clinical Implications

No dosing adjustments or timing modifications are needed based on gastric pH:

• Pitolisant does not require pre-meal dosing (unlike PPIs which must be taken 30–60 minutes before meals to achieve maximal effect). 1

• Concomitant use with acid-suppressing medications (PPIs, H2-receptor antagonists) does not require dose adjustment of Wakix based on any pH-mediated absorption changes. 1

• Patients with conditions affecting gastric acidity (achlorhydria, hypochlorhydria, or those on chronic acid suppression) can take Wakix without concern for reduced absorption. 1

Contrast with pH-Sensitive Drugs

This stands in stark contrast to weak bases like itraconazole, where gastric pH profoundly affects absorption:

• Weak base drugs can experience up to 65% reduction in exposure under achlorhydria due to pH-dependent solubility and dissolution. 2

• Pitolisant's acid-stable formulation and non-prodrug nature eliminate this vulnerability. 1